Skip to main content

Advertisement

Table 1 GP/GP trainee respondent demographics

From: Low knowledge and awareness of monoclonal gammopathy of undetermined significance (MGUS) among general practitioners

  Total (n = 58) Registered GP (n = 35) GP trainee (n = 23) p-value*
Gender
 Male 32 (55.2) 22 (62.9) 10 (43.5) 0.15
 Female 26 (44.8) 13 (37.1) 13 (56.5)  
Continent
 Europe 47 (81) 27 (77.1) 20 (87) 0.54
 The Americas 3 (5.2) 1 (2.9) 2 (8.7)
 Asian 6 (10.3) 5 (14.3) 1 (4.4)
 Africa 1 (1.7) 1 (2.9) 0
 Missing 1 (1.7) 1 (2.9) 0
Years working as a GP or trainee since completing medical degree
 0–5 years 25 (43.1) 5 (14.3) 20 (87) ≤0.001
 6–10 years 13 (22.4) 11 (31.4) 2 (8.7)
 11–20 years 13 (22.4) 13 (37.1) 0
 20+ years 7 (12.1) 6 (17.1) 1 (4.4)
GP Practice
 Metropolitan/urban 42 (72.4) 25 (71.4) 17 (73.9) 0.52
 Rural 15 (25.9) 10 (28.6) 5 (21.7)
 Prefer not to say/Not applicable 1 (1.7) 0 1 (4.4)
Number of patients within GP/Family practice
 0–500 patients 3 (5.2) 1 (2.9) 2 (8.7) 0.83
 501–1000 patients 3 (5.2) 2 (5.7) 1 (4.4)
 1001–2000 patients 25 (43.1) 16 (45.7) 9 (39.1)
 2001+ patients 27 (46.6) 16 (45.7) 11 (47.8)
Number of MGUS patients that have/are currently within GP/Family practice
 None 8 (13.8) 5 (14.3) 3 (13) 0.19
 1–10 patients 24 (41.4) 18 (51.4) 6 (26.1)
 11–50 patients 5 (8.6) 2 (5.7) 3 (13)
 51–100 patients 1 (1.7) 1 (2.9) 0
 Don’t know/Prefer not to say/Not applicable 20 (34.5) 9 (25.7) 11 (47.8)
  1. *Fisher’s exact test used to estimate p-value where cell count < 5